Literature DB >> 22169403

Modelling the benefits of a new class of anthelmintic in combination.

D M Leathwick1.   

Abstract

Since 2009 two new classes of anthelmintics have been registered for use in sheep in New Zealand. This raises challenging questions about how such new actives should be used, not only to minimise the development of resistance to them, thereby ensuring their availability as effective treatments for as long as possible, but also to minimise the further development of resistance to the other anthelmintic classes. One strategy which appears to offer considerable potential for slowing the development of resistance is the use of combinations of different anthelmintic classes, although this approach remains contentious in some countries. The potential benefit of using anthelmintics in combination is particularly relevant to two recently released anthelmintic compounds because one, monepantel, is presently only available as a single active product while the other, derquantel, is only available in combination with abamectin. A simulation modelling approach was used to investigate the potential benefits of using anthelmintics in combination. The rate at which resistance develops to a new 'active' when used alone was compared to an equivalent compound used in combination with a second compound from an alternative class (in this case, abamectin), when various levels of resistance occur to the second active. In addition, the potential of a new active to reduce further development of resistance to the second compound in the combination was evaluated. Finally, the use of combinations as compared to sequential or rotational use patterns, in the presence of side resistance between two actives was investigated. The modelling simulations suggest a significant advantage to both compounds when they are used in combination, especially if both initially have high efficacy. The development of resistance to the new active was delayed, although to a lesser extent, even when the efficacy of the second active in the combination was only 50%. Under a 'low-refugia' management environment resistance to all actives developed more rapidly, and the advantage of using actives in combination was reduced. When used in conjunction with other resistance management strategies, a combination containing a new active prevented further development of resistance to the older class. Using actives in combination was superior to using them individually either sequentially or in rotation, even in the presence of side-resistance between the two anthelmintic classes.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22169403     DOI: 10.1016/j.vetpar.2011.11.050

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  12 in total

Review 1.  Advances in diagnosis and control of anthelmintic resistant gastrointestinal helminths infecting ruminants.

Authors:  Noha M F Hassan; Alaa A Ghazy
Journal:  J Parasit Dis       Date:  2021-11-10

2.  A BRIEF REVIEW ON THE MODE OF ACTION OF ANTINEMATODAL DRUGS.

Authors:  Melanie Abongwa; Richard J Martin; Alan P Robertson
Journal:  Acta Vet (Beogr)       Date:  2017-06-26       Impact factor: 0.800

3.  Evidence for reversion towards anthelmintic susceptibility in Teladorsagia circumcincta in response to resistance management programmes.

Authors:  Dave M Leathwick; Siva Ganesh; Tania S Waghorn
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2015-02-07       Impact factor: 4.077

4.  Curiouser and Curiouser: The Macrocyclic Lactone, Abamectin, Is also a Potent Inhibitor of Pyrantel/Tribendimidine Nicotinic Acetylcholine Receptors of Gastro-Intestinal Worms.

Authors:  Melanie Abongwa; Samuel K Buxton; Alan P Robertson; Richard J Martin
Journal:  PLoS One       Date:  2016-01-11       Impact factor: 3.240

5.  Anthelmintic resistance in gastrointestinal nematodes of alpacas (Vicugna pacos) in Australia.

Authors:  Mohammed H Rashid; Jane L Vaughan; Mark A Stevenson; Angus J D Campbell; Ian Beveridge; Abdul Jabbar
Journal:  Parasit Vectors       Date:  2018-07-04       Impact factor: 3.876

Review 6.  What Modeling Parasites, Transmission, and Resistance Can Teach Us.

Authors:  Hannah Rose Vineer
Journal:  Vet Clin North Am Food Anim Pract       Date:  2020-03       Impact factor: 3.357

7.  Anthelmintics Resistance; How to Overcome it?

Authors:  Hatem A Shalaby
Journal:  Iran J Parasitol       Date:  2013-01       Impact factor: 1.012

8.  In vivo and in vitro studies of Cry5B and nicotinic acetylcholine receptor agonist anthelmintics reveal a powerful and unique combination therapy against intestinal nematode parasites.

Authors:  Yan Hu; Melanie Miller; Bo Zhang; Thanh-Thanh Nguyen; Martin K Nielsen; Raffi V Aroian
Journal:  PLoS Negl Trop Dis       Date:  2018-05-18

9.  Comprehensive evaluation of stool-based diagnostic methods and benzimidazole resistance markers to assess drug efficacy and detect the emergence of anthelmintic resistance: A Starworms study protocol.

Authors:  Johnny Vlaminck; Piet Cools; Marco Albonico; Shaali Ame; Mio Ayana; Jeffrey Bethony; Giuseppe Cringoli; Daniel Dana; Jennifer Keiser; Maria P Maurelli; Antonio Montresor; Zeleke Mekonnen; Greg Mirams; Rodrigo Corrêa-Oliveira; Roger Prichard; Nour Rashwan; Laura Rinaldi; Somphou Sayasone; Eurion Thomas; Jaco J Verweij; Jozef Vercruysse; Bruno Levecke
Journal:  PLoS Negl Trop Dis       Date:  2018-11-02

10.  Managing anthelmintic resistance in cyathostomin parasites: Investigating the benefits of refugia-based strategies.

Authors:  Dave M Leathwick; Christian W Sauermann; Martin K Nielsen
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2019-08-28       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.